J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS)
INR 1934.75
(4.25%)
INR 1934.75
(4.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 39.94 Billion INR | 12.39% |
| 2022 | 35.53 Billion INR | 36.3% |
| 2021 | 26.07 Billion INR | 16.5% |
| 2020 | 22.38 Billion INR | 23.41% |
| 2019 | 18.13 Billion INR | 1.26% |
| 2018 | 17.91 Billion INR | 1.48% |
| 2017 | 17.64 Billion INR | 5.43% |
| 2016 | 16.74 Billion INR | 7.49% |
| 2015 | 15.57 Billion INR | 4.72% |
| 2014 | 14.87 Billion INR | 10.08% |
| 2013 | 13.51 Billion INR | 3.91% |
| 2012 | 13 Billion INR | 8.55% |
| 2011 | 11.97 Billion INR | 19.85% |
| 2010 | 9.99 Billion INR | 19.4% |
| 2009 | 8.36 Billion INR | 12.15% |
| 2008 | 7.46 Billion INR | 0.68% |
| 2007 | 7.41 Billion INR | 4.07% |
| 2006 | 7.12 Billion INR | 40.97% |
| 2005 | 5.05 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 39.94 Billion INR | 12.39% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 37.99 Billion INR | 0.0% |
| 2023 Q4 | 39.94 Billion INR | 0.0% |
| 2022 Q4 | 35.53 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 32.06 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 35.53 Billion INR | 36.3% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 26.07 Billion INR | 16.5% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 26.07 Billion INR | 0.0% |
| 2021 Q2 | 24.16 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 20.53 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 22.38 Billion INR | 23.41% |
| 2020 Q4 | 22.38 Billion INR | 0.0% |
| 2019 Q4 | 18.13 Billion INR | 0.0% |
| 2019 Q2 | 19.55 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 18.13 Billion INR | 1.26% |
| 2019 Q3 | - INR | -100.0% |
| 2018 FY | 17.91 Billion INR | 1.48% |
| 2018 Q4 | 17.91 Billion INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 17.64 Billion INR | 5.43% |
| 2016 Q4 | 16.74 Billion INR | 0.0% |
| 2016 FY | 16.74 Billion INR | 7.49% |
| 2015 FY | 15.57 Billion INR | 4.72% |
| 2015 Q4 | 15.57 Billion INR | 0.0% |
| 2014 FY | 14.87 Billion INR | 10.08% |
| 2013 FY | 13.51 Billion INR | 3.91% |
| 2012 FY | 13 Billion INR | 8.55% |
| 2011 FY | 11.97 Billion INR | 19.85% |
| 2010 FY | 9.99 Billion INR | 19.4% |
| 2009 FY | 8.36 Billion INR | 12.15% |
| 2008 FY | 7.46 Billion INR | 0.68% |
| 2007 FY | 7.41 Billion INR | 4.07% |
| 2006 FY | 7.12 Billion INR | 40.97% |
| 2005 FY | 5.05 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sigachi Industries Limited | 6.94 Billion INR | -475.393% |
| Ind-Swift Limited | 6.54 Billion INR | -510.283% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -422.021% |
| Sakar Healthcare Limited | 3.88 Billion INR | -927.669% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 91.138% |
| Innova Captab Limited | 13.2 Billion INR | -202.384% |
| Divi's Laboratories Limited | 154.7 Billion INR | 74.181% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -270.503% |
| Morepen Laboratories Limited | 12.93 Billion INR | -208.855% |
| Mankind Pharma Limited | 119.63 Billion INR | 66.613% |
| Sequent Scientific Limited | 15.4 Billion INR | -159.294% |
| Wanbury Limited | 3.43 Billion INR | -1062.798% |
| Laurus Labs Limited | 83.87 Billion INR | 52.377% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -82.292% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -40.125% |
| Alembic Limited | 23.28 Billion INR | -71.512% |
| Hikal Limited | 24.87 Billion INR | -60.591% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 38.033% |
| Neuland Laboratories Limited | 18.32 Billion INR | -117.953% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 72.183% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -77.96% |
| Themis Medicare Limited | 5.66 Billion INR | -605.158% |
| RPG Life Sciences Limited | 5.12 Billion INR | -678.78% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 86.359% |
| Lupin Limited | 239.97 Billion INR | 83.356% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -988.702% |
| Wockhardt Limited | 76.49 Billion INR | 47.782% |
| Vaishali Pharma Limited | 799.55 Million INR | -4895.429% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -54.685% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1739.952% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 65.414% |
| FDC Limited | 24.68 Billion INR | -61.831% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 89.693% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -1563.794% |
| Eris Lifesciences Limited | 70.48 Billion INR | 43.336% |
| Venus Remedies Limited | 6.26 Billion INR | -537.195% |
| ZIM Laboratories Limited | 4.46 Billion INR | -793.897% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -229.041% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -3830.801% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -48.074% |
| Shilpa Medicare Limited | 30.93 Billion INR | -29.126% |
| Albert David Limited | 4.97 Billion INR | -702.048% |
| Ajanta Pharma Limited | 46.38 Billion INR | 13.89% |
| Hester Biosciences Limited | 6.62 Billion INR | -503.027% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -77.195% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -70.209% |
| Gufic Biosciences Limited | 10.92 Billion INR | -265.582% |
| Windlas Biotech Limited | 6.26 Billion INR | -537.83% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -402.811% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -1209.585% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -1097.912% |
| Granules India Limited | 55.2 Billion INR | 27.655% |
| Aarti Drugs Limited | 24.32 Billion INR | -64.208% |
| Bal Pharma Limited | 3.2 Billion INR | -1146.65% |
| Alkem Laboratories Limited | 155.74 Billion INR | 74.355% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 95.326% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -470.353% |
| Medicamen Biotech Limited | 2.94 Billion INR | -1256.138% |
| Unichem Laboratories Limited | 31.69 Billion INR | -26.024% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -2604.555% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -8383.222% |
| Valiant Laboratories Limited | 3.42 Billion INR | -1065.532% |
| Orchid Pharma Limited | 15.53 Billion INR | -157.043% |
| Medico Remedies Limited | 961.95 Million INR | -4052.105% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -242.812% |
| Ipca Laboratories Limited | 111.01 Billion INR | 64.021% |
| Brooks Laboratories Limited | 904.45 Million INR | -4316.068% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -887.024% |
| Piramal Enterprises Limited | 826.05 Billion INR | 95.165% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 73.48% |
| NATCO Pharma Limited | 69.06 Billion INR | 42.167% |
| Suven Life Sciences Limited | 2.84 Billion INR | -1301.928% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -2141.693% |
| Strides Pharma Science Limited | 58.39 Billion INR | 31.604% |
| Indoco Remedies Limited | 21.44 Billion INR | -86.23% |
| Alpa Laboratories Limited | 1.82 Billion INR | -2087.106% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -2547.421% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -675.499% |